Skip to content
777 Sourcing.

Capability

allosteric drug discovery

Suppliers
1
States & provinces
1
Countries
1

1 allosteric drug discovery supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

ATAVISTIK BIO, INC.

CAMBRIDGE, MA

Atavistik Bio is a clinical stage biotechnology company developing novel allosteric therapeutics. Its approach enables selective modulation of disease-causing proteins. The company is advancing multiple programs, including its lead asset ATV-1601, an oral allosteric AKT1-selective inhibitor for Hereditary Hemorrhagic Telangiectasia (HHT), and a JAK2 V617F mutant-selective inhibitor program for myeloproliferative neoplasms. It has built a versatile discovery platform that identifies functional pockets across protein classes, with an internal focus on rare

cheminformaticsclinical developmentCMCDMPKmedicinal chemistryRegulatory Affairstranslational research

Compiled from public sources

Related capabilities

Other processes offered by the shops that list allosteric drug discovery.

Browse all capabilities